Skip to main content
رجوع
QDEL logo

QuidelOrtho Corporation

جودة البيانات: 100%
QDEL
NASDAQ Healthcare Medical - Instruments & Supplies
KWD 16.01
▼ KWD 0.16 (-0.99%)
القيمة السوقية: 1.09B
نطاق اليوم
KWD 15.52 KWD 16.73
نطاق 52 أسبوعًا
KWD 15.08 KWD 38.99
حجم التداول
1,974,807
متوسط 50 يوم / 200 يوم
KWD 25.26 / KWD 26.99
الإغلاق السابق
KWD 16.17

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -1.0 0.3
P/B 0.6 3.0
ROE % -46.2 3.7
Net Margin % -41.5 3.8
Rev Growth 5Y % 12.6 10.0
D/E 1.5 0.2

السعر المستهدف للمحللين

Hold
KWD 30.00 +87.4%
مكرر الربحية المستقبلي
7.46
ربحية السهم المستقبلية
KWD 2.15
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.77B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 3.10
KWD 3.07 – KWD 3.12
3.11B 1
FY2029 KWD 3.78
KWD 3.74 – KWD 3.80
3.09B 1
FY2028 KWD 3.47
KWD 3.44 – KWD 3.49
3.00B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-11 KWD 0.42 KWD 0.46 +9.1%
2025-11-05 KWD 0.51 KWD 0.80 +56.9%
2025-08-05 KWD 0.56 KWD 0.12 -78.6%
2025-05-07 KWD 0.58 KWD 0.74 +27.6%
2025-02-12 KWD 0.55 KWD 0.63 +14.5%
2024-11-07 KWD 0.31 KWD 0.85 +174.2%
2024-07-31 -KWD 0.21 -KWD 0.07 +66.7%
2024-05-08 KWD 0.43 KWD 0.44 +2.3%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

النقاط الرئيسية

Revenue grew 12.60% annually over 5 years — strong growth
Negative free cash flow of -83.00M
PEG of 0.04 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 14.49%
Capital efficient — spends only 6.89% of revenue on capex

النمو

Revenue Growth (5Y)
12.60%
Revenue (1Y)-1.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-46.15%
ROIC-14.59%
Net Margin-41.45%
Op. Margin-33.67%

الأمان

Debt / Equity
1.46
Current Ratio1.50
Interest Coverage-5.18

التقييم

P/E Ratio
-0.96
Forward P/E7.71
P/B Ratio0.57
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -1.89% Revenue Growth (3Y) -4.57%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 12.60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.73B Net Income (TTM) -1.13B
ROE -46.15% ROA -19.62%
Gross Margin 46.67% Operating Margin -33.67%
Net Margin -41.45% Free Cash Flow (TTM) -83.00M
ROIC -14.59% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.46 Current Ratio 1.50
Interest Coverage -5.18
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.96 Forward P/E 7.71
P/B Ratio 0.57 P/S Ratio 0.40
PEG Ratio 0.04 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA 17.48
Forward P/S 0.39 Fwd Earnings Yield 12.97%
FCF Yield -7.61%
Market Cap 1.09B Enterprise Value 3.72B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.73B 2.78B 3.00B 3.27B 1.70B
Net Income -1.13B -2.05B -10.10M 548.70M 704.20M
EPS (Diluted) -16.69 -30.54 -0.15 9.56 16.43
Gross Profit 1.27B 1.29B 1.50B 1.94B 1.28B
Operating Income -919.20M -1.96B 139.10M 843.70M 906.00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.77B 6.42B 8.56B 8.86B 2.43B
Total Liabilities 3.85B 3.44B 3.56B 3.92B 501.00M
Shareholders' Equity 1.92B 2.98B 5.01B 4.93B 1.93B
Total Debt 2.80B 2.68B 2.61B 2.85B 139.30M
Cash & Equivalents 169.80M 98.30M 118.90M 292.90M 802.80M
Current Assets 1.45B 1.22B 1.31B 1.58B 1.44B
Current Liabilities 966.10M 998.80M 833.80M 1.01B 323.50M